Nag A. Intraocular and Ocular Adnexal Metastases: A Comprehensive Review.
Ocul Oncol Pathol. 2026 Apr 10. doi: 10.1159/000551923. Epub ahead of print. PMID: 42325542; PMCID: PMC13282122.
Our care team will contact you shortly.
At Susrut Eye Foundation & Research Centre, research is an integral part of our commitment to advancing eye care. Our clinical research draws on the breadth of subspecialty expertise across the institution and focuses on questions that arise directly from patient care.
Every patient encounter is an opportunity to learn, improve and contribute to the future of eye care.
Alongside providing comprehensive clinical services, our clinicians contribute to the growing evidence base in ophthalmology and vision science, through clinical studies, collaborative research and scientific publications,
Research at Susrut spans multiple ophthalmic subspecialties with particularly strong contributions in vitreoretinal diseases and ocular oncology, alongside research in cornea and ocular surface disease, glaucoma, neuro-ophthalmology, paediatric ophthalmology, refractive disorders and anterior-segment disease.
Turning clinical experience into better outcomes for future patients.
Collaboration forms an important part of our academic endeavour. Susrut Eye Foundation & Research Centre has participated in multicentre research involving institutions and investigators across geographical boundaries.
Our participation in the Global Retinoblastoma Study Group contributed to a major international study examining the clinical presentation and treatment outcomes of 2,112 patients with retinoblastoma across 33 countries in Asia. Published in Ophthalmology, the study represents a large-scale collaborative effort to better understand regional patterns of presentation, management and outcomes in retinoblastoma.
Kaliki S, Vempuluru VS, Mohamed A, Al-Jadiry MF, Bowman R, Chawla B, Hamid SA, Ji X, Kapelushnik N, Kebudi R, Sthapit PR, Rojanaporn D, Sitorus RS, Yousef YA, Fabian ID; Global Retinoblastoma Study Group. Retinoblastoma in Asia: Clinical Presentation and Treatment Outcomes in 2112 Patients from 33 Countries. Ophthalmology. 2024 Apr;131(4):468-477. doi: 10.1016/j.ophtha.2023.10.015. Epub 2023 Oct 13. PMID: 37839559. (Dr A Bhaduri)
Multicentre and international research enables the institution to contribute clinical data and expertise to larger questions in ophthalmology while bringing insights from global research collaborations into clinical practice.
Our consultants contribute to peer-reviewed ophthalmic and medical literature across a range of subspecialties.
Ocul Oncol Pathol. 2026 Apr 10. doi: 10.1159/000551923. Epub ahead of print. PMID: 42325542; PMCID: PMC13282122.
Indian Journal of Ophthalmology - Case Reports, 6(2), 668–669.
View DOIRetina Today. 2026, March.
View ArticleIndian Journal of Ophthalmology - Case Reports, 6(2), 692.
View DOISeminars in Ophthalmology, 40(7), 609–617.
View DOIBritish Journal of Ophthalmology. 2025;109:735–741.
Indian Journal of Ophthalmology, 73(4), 594–598.
View DOIOphthalmology Retina. 2025;9(4):e38.
Clinical Ophthalmology. 2025;19:1093–1102. doi:10.2147/OPTH.S515479.
International Journal of Science and Research (IJSR). 2024;13(12):974–979.
COVID-19 Vaccines - Current State and Perspectives. IntechOpen; 2023.
View DOIInternational Journal of Dental and Medical Sciences Research. 2023;5(5):487–493. doi:10.35629/5252-0505487493.
Indian Journal of Ophthalmology. 2023;71(6):2500–2503. doi:10.4103/IJO.IJO_25_23.
Indian J Ophthalmol. 2022 Feb;70(2):679–683. doi:10.4103/ijo.IJO_2374_21. PMID: 35086265; PMCID: PMC9023989.
Oman J Ophthalmol. 2022 Mar 2;15(1):119–120. doi:10.4103/ojo.ojo_144_21. PMID: 35388264; PMCID: PMC8979398.
Indian Journal of Ophthalmology - Case Reports, 2(1), 310.
View DOIIndian Journal of Ophthalmology - Case Reports, 1(4), 739–741.
View DOIInternational Journal Of Retina, 4(2), 178. doi:10.35479/ijretina.2021.vol004.iss002.166
Ocul Oncol Pathol. 2021 Jun;7(3):177–181. doi:10.1159/000512173. Epub 2021 Jan 7. PMID: 34307328; PMCID: PMC8280437.
Indian J Ophthalmol. 2021 Nov;69(11):3283–3287. doi:10.4103/ijo.IJO_1264_21. PMID: 34708788; PMCID: PMC8725105.
No publications found for the selected filters.
Clinicians at Susrut have received recognition at various scientific meetings and professional forums.
Gaurav Chauhan
Nilay Kumar Majumdar
Adwaita Nag
Madhurima Roy
Madhurima Roy
Hari Shanker Nag
Academic enquiry is an important component of clinical training. Through exposure to research methodology, scientific writing, critical appraisal and presentation of clinical work, trainees are encouraged to engage with ophthalmology not only as practitioners, but also as contributors to its evolving evidence base.
Clinical research carries a responsibility towards patients, the medical community and society.
Any research involving patients is conducted in accordance with applicable ethical, regulatory and institutional requirements, with appropriate safeguards for patient rights, privacy, informed consent and safety.
At Susrut, the goal is not research for its own sake.
Our aim is to build on Susrut's clinical strengths to develop a growing and collaborative research programme—one that asks meaningful questions, encourages academic enquiry and translates clinical experience into knowledge that can improve eye care.
Through continued research, collaboration and scientific exchange, we hope to strengthen Susrut's contribution to ophthalmology, both in India and beyond.
Susrut welcomes opportunities for meaningful academic and research collaboration with institutions and investigators working to advance ophthalmic care.
We welcome opportunities for meaningful academic and research collaboration. Potential areas of collaboration may include clinical research, ophthalmic education, technology-enabled eye care, community eye health, outcomes research and capacity building.